An in vivo function for the transforming Myc protein: elicitation of the angiogenic phenotype.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (63)
Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
1996 • 6,878 citations
Induction of apoptosis in fibroblasts by c-myc protein
1992 • 2,977 citations
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
1983 • 2,871 citations
Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor
1983 • 2,350 citations
Max: A Helix-Loop-Helix Zipper Protein That Forms a Sequence-Specific DNA-Binding Complex with Myc
1991 • 1,650 citations
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
1994 • 1,460 citations
The implications of angiogenesis for the biology and therapy of cancer metastasis
1994 • 1,120 citations
A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin.
1990 • 1,062 citations
Molecular architecture of basement membranes
1990 • 937 citations
Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
1997 • 841 citations
A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins
1995 • 798 citations
Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation
1984 • 785 citations
Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis.
1995 • 766 citations
Role for c-myc in Activation-Induced Apoptotic Cell Death in T Cell Hybridomas
1992 • 705 citations
A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1
1987 • 696 citations
Cdc25 cell-cycle phosphatase as a target of c-myc
1996 • 691 citations
The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture.
1999 • 638 citations
Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation
1995 • 603 citations
A murine tumor producing a matrix of basement membrane.
1977 • 602 citations
Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice.
1999 • 599 citations
V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression.
1997 • 526 citations
How Tumors Become Angiogenic
1996 • 514 citations
Mice That Lack Thrombospondin 2 Display Connective Tissue Abnormalities That Are Associated with Disordered Collagen Fibrillogenesis, an Increased Vascular Density, and a Bleeding Diathesis
1998 • 488 citations
Myc and Max proteins possess distinct transcriptional activities
1992 • 478 citations
Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells
1989 • 475 citations
Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways
1997 • 470 citations
Reversible Activation of c-Myc in Skin
1999 • 468 citations
Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max
1992 • 458 citations
Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia.
1998 • 451 citations
The molecular role of Myc in growth and transformation: recent discoveries lead to new insights
1998 • 381 citations
Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ
1989 • 360 citations
c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II.
1994 • 313 citations
A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells
1990 • 313 citations
Myc target genes
1997 • 289 citations
Control of cell proliferation by Myc
1998 • 251 citations
IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: Demonstration of a novel role for c-myc
1992 • 242 citations
Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line.
1990 • 230 citations
Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines
1994 • 222 citations
Reciprocal paracrine interactions between tumour cells and endothelial cells: the ‘angiogenesis progression’ hypothesis
1996 • 212 citations
Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo.
1996 • 210 citations
Inhibition of Angiogenesis by Thrombospondin-2
1995 • 200 citations
Angiogenesis in the Mouse Cornea
1979 • 188 citations
Temporally and spatially regulated somatic mutagenesis in mice
1998 • 187 citations
Role of the SIKVAV Site of Laminin in Promotion of Angiogenesis and Tumor Growth: An In Vivo Matrigel Model
1992 • 185 citations
Angiogenesis spectrum in the stroma of B‐cell non‐Hodgkin's lymphomas. An immunohistochemical and ultrastructural study
1996 • 183 citations
Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling
1991 • 175 citations
Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration.
1993 • 165 citations
Myc represses the growth arrest gene gadd45
1997 • 149 citations
Establishing a Link between Oncogenes and Tumor Angiogenesis
1998 • 148 citations
Neoplastic transformation by the human gene N-myc.
1987 • 124 citations
Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
1996 • 121 citations
SPARC and thrombospondin genes are repressed by the c-jun oncogene in rat embryo fibroblasts.
1994 • 108 citations
Viral Myc Oncoproteins in Infected Fibroblasts Down-modulate Thrombospondin-1, a Possible Tumor Suppressor Gene
1996 • 92 citations
Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-responsive T47D breast cancer cells in vitro.
1990 • 82 citations
Cell cycle: On target with Myc
1996 • 81 citations
Assay and purification of naturally occurring inhibitor of angiogenesis
1991 • 73 citations
Down‐regulation of endothelial cell growth inhibitors by enhanced MYCN oncogene expression in human neuroblastoma cells
1999 • 60 citations
Establishment of a Cell Line from the EHS Tumor: Biosynthesis of Basement Membrane Constituents and Characterization of a Hybrid Proteoglycan Containing Heparan and Chondroitin Sulfate Chains
1992 • 50 citations
Transformation by v-src causes transient induction followed by repression of mouse thrombospondin-1.
1994 • 50 citations
Tumour suppressor genes and angiogenesis: the role of TP53 in fibroblasts
1996 • 38 citations
Myb-dependent Regulation of Thrombospondin 2 Expression
1998 • 34 citations
Overproduction of v-Myc in the Nucleus and Its Excess Over Max Are Not Required for Avian Fibroblast Transformation
1993 • 13 citations
Characterization of c-myc-Transformed Rat Fibroblasts Resistant to Apoptosis Induced by Growth Factor Deprivation
1996 • 6 citations
Cited By (0)
No citing papers found in database